GHRP-6

GHRP-6 is a ghrelin-mimetic growth hormone secretagogue studied for GH release, recovery, appetite stimulation, and body-composition support.

Profile · 01

Overview

GHRP-6 is a synthetic hexapeptide that stimulates growth hormone release by binding the ghrelin receptor, also called GHS-R1a. It is not FDA-approved for any indication, but it has a larger preclinical and pharmacologic literature base than many research peptides.

Compared with more selective secretagogues like Ipamorelin, GHRP-6 is more strongly associated with appetite stimulation and is often discussed in multi-dose daily protocols because of its short half-life.

At a Glance

Goal

Support pulsatile GH release, recovery, and body-composition signaling while accounting for strong appetite effects

Protocol

Suggested three-times-daily titration approach starting lower and increasing every two weeks.

Reconstitute

Add 3.0 mL bacteriostatic water to a 2 mg vial for about 0.67 mg/mL concentration

Typical daily range

300-900 mcg total per day, split into 3 doses

Start

100 mcg per injection, 3 times daily

Target

300 mcg per injection, 3 times daily by Weeks 5-12

Frequency

Three times per day (subcutaneous), spaced at least 4 hours apart

Cycle Length

8-12 weeks

Timing

Morning, midday, and bedtime on an empty stomach

Route

Subcutaneous

Cycle

8-12 weeks on, 4 weeks off

Inject three times daily on an empty stomach using the 3.0 mL dilution so per-dose volume stays readable. The source emphasizes that the short half-life supports repeated daily dosing, but that also makes adherence and site rotation more demanding than once-daily peptides.

Dose progression

Weeks 1-2

100 mcg (0.1 mg) · 15 units (0.15 mL)

Weeks 3-4

200 mcg (0.2 mg) · 30 units (0.30 mL)

Weeks 5-12

300 mcg (0.3 mg) · 45 units (0.45 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How GHRP-6 works.

GHRP-6 acts as a ghrelin mimetic at GHS-R1a receptors, promoting acute pulsatile GH release while preserving physiologic feedback loops. The source also highlights broader cytoprotective and tissue-repair discussion through pathways such as CD36 and PI3K/Akt in preclinical work.

Because the half-life is short, repeated daily administration is common in research discussions. Appetite stimulation is a major differentiator versus more selective secretagogues like Ipamorelin.

Science · 02

Effects

Observations from clinical or preclinical literature.

Supports GH and IGF-1 elevation through repeated pulsatile signaling

May support lean-mass gain and fat-loss goals through GH-axis activation

Frequently increases appetite, which can be either useful or undesirable depending on the goal

Preclinical literature discusses wound-healing, cardioprotective, and cytoprotective effects

Mild injection-site irritation, flushing, or dizziness may occur

Water retention or increased hunger are common practical considerations

Science · 03

Caution

Use caution in active cancer or significant cancer history because GH/IGF-1 signaling can be growth-promoting

Not recommended during pregnancy or breastfeeding because safety data is insufficient

Use caution in diabetes, insulin resistance, or appetite-dysregulation contexts

Consult a qualified healthcare provider before use if you have chronic endocrine or metabolic disease

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Zinc

Supports GH-related signaling and immune function.

Magnesium

Supports recovery and broader hormonal physiology.

Vitamin D

Relevant to endocrine and musculoskeletal support.

B vitamins

Support energy metabolism and recovery during higher-frequency protocols.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Time meals carefully because the protocol is typically performed on an empty stomach

Use resistance training and adequate protein intake to reinforce anabolic goals

Prioritize 7-9 hours of quality sleep to support natural GH biology

Plan for appetite changes rather than treating them as a surprise side effect

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

Body composition - track lean mass, fat mass, and overall weight trends
Appetite and food intake - monitor because hunger can meaningfully change adherence
Sleep quality and recovery - track whether multi-dose administration is supporting the intended goal
Injection-site reactions - track redness, swelling, or discomfort across frequent injections

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

IGF-1

Primary downstream marker of GH-axis response.

Fasting glucose and HbA1c

Monitor broader metabolic response to GH-axis stimulation.

CBC (Complete Blood Count)

General monitoring and baseline screening.

CMP (Comprehensive Metabolic Panel)

Assess liver and kidney function during peptide use.

Cortisol and prolactin

Useful if symptoms suggest broader hormonal spillover effects.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length

Vial size

Bac. water

Syringe

Vials

0 × 2 mg each…

Syringes

Bac. water

0 mL

Swabs

02 per syringe

Calculators · 02

Dose Calculator

Vial

Bac. water

Syringe

Dose

Concentration

0mcg/mL

Volume per dose

0mL

…

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

Allow vial to reach room temperature for 15–20 minutes before reconstitution.
Draw the chosen bacteriostatic water volume with a sterile syringe.
Inject slowly down vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully

Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue

Do not aspirate for subcutaneous injections; inject slowly and steadily

Rotate between abdomen, thighs, and upper arms to reduce lipohypertrophy risk

Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized

Store at room temp in dry, dark conditions; minimize moisture exposure.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely

This is a high-touch protocol because it requires three injections per day

Plan around appetite stimulation and empty-stomach timing requirements

Document dose timing and site rotation carefully because injection frequency is high

PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

European Journal of Endocrinology
Growth hormone-releasing peptide review literature and GHRP-6 context.
https://academic.oup.com/ejendo/article/136/3/251/6860488
European Journal of Pharmaceutical Sciences
Pharmacokinetic study of GHRP-6.
https://pubmed.ncbi.nlm.nih.gov/23665399/
Clinical Medicine Insights: Cardiology
Historical appraisal of synthetic GHRP mechanisms and cytoprotective effects.
https://journals.sagepub.com/doi/10.1177/1179546817694558
Sexual Medicine Reviews
Safety and efficacy review of growth hormone secretagogues.
https://pubmed.ncbi.nlm.nih.gov/29937324/
CDC
Subcutaneous injection route guidance.
https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf